PUBLIC COMPANY
save$ALXOALX ONCOLOGY HOLDINGS INC
$ALXOSouth San Francisco, CA, USupdated 11d ago
community read0 votes
pipeline
2
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 11Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- phase2ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- phase3A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
- phase2Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)
- phase1A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
- phase2Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)
- phase1A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)
- phase1A Study of Evorpacept (ALX148) With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02)
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (4)
- Apr 16, 26grantKlencke Barbara · Chief Medical Officer100,000 sh
- Apr 16, 26grantKnight Jeff E. · Chief Dev & Operating Officer800,000 sh
- Mar 3, 26grantKlencke Barbara · Chief Medical Officer700,000 sh
- Feb 17, 26tax coverLettmann Jason · CHIEF EXECUTIVE OFFICER2,201 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 15m ago
Found something off?
comments(0)
5-min edit window · permanent after that